Trial 3C-15-1


An Open-Label Expanded Access Study of Tas-102 in Patients with Metastatic Colorectal Cancer Refractory to or Failing Standard Chemotherapy

Type: Other
Phase: Not Applicable
Status: Not Open (Closed)
Treatments: Chemotherapy: Systemic
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Heinz Josef Lenz, M.D.
Other Trial Staff:  Ramona Lujan, R.N., Raluca Agafitei, Coordinator, Mary Ordaz, D.M., Marile Garcia, R.N., Jennifer Berg, Coordinator, Catherine Ticong, R.N., Judy Lam-Tran, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.